Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1Phase 1 1

Status

Unknown 58Completed 27Terminated 4Recruiting 1Not yet recruiting 1Available 1

Sponsor Class

OTHER 1107INDUSTRY 584NIH 84NETWORK 35OTHER_GOV 15INDIV 5UNKNOWN 4FED 3

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

Gastrointestinal 4Thoracic 1Head & Neck 1Gynecologic 1Genitourinary 1Dermatologic 1Breast 1

Conditions

Stomach Neoplasms 2Carcinoma, Hepatocellular 2Urinary Bladder Neoplasms 1Ovarian Neoplasms 1Neoplasms 1Melanoma 1Colorectal Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Adenocarcinoma 1

Interventions

titanium silicide 1pembrolizumab 1Taxes 1S 1 (combination) 1Albumin-Bound Paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Terminated × UNKNOWN × Gastrointestinal × Clear all
NCT02346955 2020-08-27

MK-6018-001

KitovPharma

Phase 1 Terminated
27 enrolled
DermatologicGastrointestinalGenitourinaryGynecologicThoracic

Adenocarcinoma, Urinary Bladder Neoplasms, Carcinoma, Non-Small-Cell Lung, Melanoma, Neoplasms, Ovarian Neoplasms, Stomach Neoplasms, Colorectal Neoplasms

NCT02967523 2018-09-11

Surefire Precision Infusion System Registry

SurefireMedical

Terminated
111 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT02748161 2018-06-21

QED

SurefireMedical

Phase NA Terminated
170 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT01980810 2016-06-14

GC-A-003

ChineseAMS

Phase 2 Terminated
36 enrolled
Gastrointestinal

Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡